When septic arthritis arises from Mycobacterium tuberculosis joint infection, it represents an extrapulmonary form of tuberculosis requiring a management approach that differs substantially from typical bacterial arthritis.
Mycobacterium tuberculosis joint infection is a recognised extrapulmonary manifestation of tuberculosis. It presents as septic arthritis in a patient with active or prior TB exposure, and requires identification of the mycobacterial aetiology to guide appropriate therapy.
The cornerstone of treatment involves a rifampin-containing regimen, generally used as part of a broader multidrug approach. Management of this condition is typically carried out in consultation with an infectious disease specialist. The complete protocol — full regimen composition, sequencing, and clinical monitoring guidance — is available through the link below.
Full drug combinations, treatment algorithm, and clinical details are in the structured protocol.
Joint infections are a known extrapulmonary manifestation of Mycobacterium tuberculosis infection, occurring in 2% of patients with tuberculosis.
Rifampin, often with a multidrug regimen (in consultation with an infectious disease specialist).
View source ↗